1. Organization WH. The evolving threat of antimicrobial resistance: options for action: World Health Organization; 2012.
2. Westly E. India moves to tackle antibiotic resistance. Nature. 2012;489(7415):192.
3. Alvarez-Uria G, Zachariah S, Thomas D. High prescription of antimicrobials in a rural district hospital in India. Pharm Pract (Granada). 2014;12(2):384.
4. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011;11(9):692-701.
5. Kotwani A, Holloway K. Access to antibiotics in New Delhi, India: implications for antibiotic policy. J Pharm Policy Pract. 2013;6:6.
6. Laxminarayan R, Heymann DL. Challenges of drug resistance in the developing world. BMJ. 2012;344:e1567.
7. Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.
8. Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002;8(3):278-82.
9. J. ON. Antimicrobial resistance: tackling a crisis for the health and wealth of nations, The review on antimicrobial resistance. 2014.
10. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis. 2005;5(8):481-93.
11. Organization WH. Global Action Plan on Antimicrobial Resistance. 2015.
12. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742-50.
13. Deshpande K, Ravi Shankar, Diwan V, Lonnroth K, Mahadik VK, Chandorkar RK. Spatial pattern of private health care provision in Ujjain, India: a provider survey processed and analysed with a Geographical Information System. Health Policy. 2004;68(2):211-22.
14. Organization WH. Health statistics 2009 [Available from:
http://who.int/whosis/whostat/EN_WHS09_Full.pdf.
15. P C. Healthcare in India: Features of one of the most privatised systems in the world; 1 September 2009.
16. Kumar R, Indira K, Rizvi A, Rizvi T, Jeyaseelan L. Antibiotic prescribing practices in primary and secondary health care facilities in Uttar Pradesh, India. J Clin Pharm Ther. 2008;33(6):625-34.
17. Sharma M, Eriksson B, Marrone G, Dhaneria S, Lundborg CS. Antibiotic prescribing in two private sector hospitals; one teaching and one non-teaching: a cross-sectional study in Ujjain, India. BMC Infect Dis. 2012;12:155.
18. Kumar SG, Adithan C, Harish BN, Sujatha S, Roy G, Malini A. Antimicrobial resistance in India: A review. J Nat Sci Biol Med. 2013;4(2):286-91.
19. Organization WH. World Health Statistics. 2014.
20. John J. IAP Policy on Age of Children for Pediatric Care. Indian Pedciatrics. 1999;36:461-3.
21. Organization WH. Introduction to Drug Utilization Research. 2003.
22. Organization WH. International Statistical Classificatoion of Disease and Related Health Problems - 10th revision. 2010.
23. Organization WH. Collaborating centre for drug statistics methodology, anatomical therapeutic chemical classification with defined daily doses 2017 [Available from:
https://www.whocc.no/atc_ddd_index/.
24. Directorate General of Health Services MoHaFW, Government of India. National List of Essential Medicines 2011 [Available from:
https://www.nhp.gov.in/national-list-of-essential-medicines-2011_pg.
25. Blumenthal D. Doctors and drug companies. N Engl J Med. 2004;351(18):1885-90.
26. Saviteer SM, Samsa GP, Rutala WA. Nosocomial infections in the elderly. Increased risk per hospital day. Am J Med. 1988;84(4):661-6.
27. Pathak A, Saliba EA, Sharma S, Mahadik VK, Shah H, Lundborg CS. Incidence and factors associated with surgical site infections in a teaching hospital in Ujjain, India. Am J Infect Control. 2014;42(1):e11-5.
28. Organization WH. Global Strategy for Containment of Antimicrobial Resistance. 2001.
29. Sharma M, Damlin AL, Sharma A, Stalsby Lundborg C. Antibiotic prescribing in medical intensive care units--a comparison between two private sector hospitals in Central India. Infect Dis (Lond). 2015;47(5):302-9.
30. Kumar S, Bansal D, Hota D, Jain M, Singh P, Pandey BL. Assessment of clinical outcomes and prescribing behavior among inpatients with severe preeclampsia and eclampsia: an Indian experience. Indian J Pharmacol. 2014;46(1):18-23.
31. Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev. 2014(10):CD007482.
32. van Schalkwyk J, Van Eyk N, Society of O, Gynaecologists of Canada Infectious Diseases C. Antibiotic prophylaxis in obstetric procedures. J Obstet Gynaecol Can. 2010;32(9):878-92.
33. Sharma JB, Gupta N, Aggarwal P, Mittal S. A survey of obstetricians' practice of using prophylactic antibiotics in vaginal deliveries and caesarean sections. J Indian Med Assoc. 2008;106(3):147-9.
34. Kulkarni Ra KR, Kochhar P, Dargude V, Rajadhyakshya S, et al. Patterns of antimicrobial use by surgeons in India. Indian J Surg 2005;67(6):308–15.
35. Ristic S, Miljkovic B, Vezmar S, Stanojevic D. Are local clinical guidelines useful in promoting rational use of antibiotic prophylaxis in caesarean delivery? Pharm World Sci. 2010;32(2):139-45.
36. Liabsuetrakul T, Lumbiganon P, Mori R, Gulmezoglu M, Souza JP, Maternal WHOGSo, et al. A secondary analysis of the WHO Global Survey on Maternal and Perinatal Health for antibiotics used in vaginal deliveries. Int J Gynaecol Obstet. 2014;124(3):240-3.
37. Sharma M, Sanneving L, Mahadik K, Santacatterina M, Dhaneria S, Stålsby Lundborg C. Antibiotic prescribing in women during and after delivery in a non-teaching, tertiary care hospital in Ujjain, India: a prospective cross-sectional study. J Pharm Policy Pract. 2013;6:9.
38. Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam M. Antibiotic prophylaxis for operative vaginal delivery. Cochrane Database Syst Rev. 2004(3):CD004455.